[Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities]

K Didier1, A Robbins1, F Antonicelli2

  • 1Service de médecine interne, maladies infectieuses et immunologie clinique, faculté de médecine de Reims, CHU de Reims, 51100 Reims, France; EA 7509 Immuno-régulation et remodelage tissulaire dans le cancer et dans les maladies auto-immunes et inflammatoires, université Reims Champagne Ardenne, 51100 Reims, France.

La Revue De Medecine Interne
|July 15, 2019
PubMed

Insights

Systemic sclerosis involves fibrosis and immune issues, with oxidative stress a key factor. While treatments are limited, autologous stem cell transplants show promise for severe cases, despite risks.

Area of Science:

  • Rheumatology
  • Immunology
  • Fibrosis Research

Background:

  • Systemic sclerosis is a rare connective tissue disease featuring fibrosis, vasculopathy, and immune abnormalities.
  • The precise origin and chronological development of systemic sclerosis pathogenesis remain incompletely understood.
  • Oxidative stress, influenced by genetic and environmental factors, is implicated in early disease phases.

Purpose of the Study:

  • To review recent advancements in understanding systemic sclerosis pathogenesis.
  • To explore the implications of new pathogenic insights for current and future medical care.
  • To highlight novel therapeutic opportunities arising from a deeper knowledge of the disease.

Main Methods:

  • Literature review focusing on recent research in systemic sclerosis.
  • Analysis of studies investigating the role of oxidative stress and immune cells.
  • Evaluation of current and emerging therapeutic strategies.

Main Results:

  • Fibroblast and endothelial cell dysfunction, alongside immune cell involvement, are key features.
  • Oxidative stress appears crucial in early fibrosis, vasculopathy, and immune tolerance.
  • Autologous hematopoietic stem cell transplantation offers lasting fibrosis regression in severe cases but carries significant toxicity.

Conclusions:

  • Recent discoveries have illuminated new mechanisms in systemic sclerosis pathogenesis.
  • These insights are paving the way for improved therapeutic strategies.
  • Further research into pathogenic pathways is essential for developing effective treatments.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
740
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
593
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K